Using claims data instead of self-reports, a team of researchers in Germany evaluated adherence to endocrine therapy on recurrence and mortality in early breast cancer. High adherence to endocrine ...

The landscape of breast cancer detection continues to evolve, with medical understanding now emphasizing personalized knowledge of breast tissue over rigid examination routines. This shift reflects ...

Unopposed estrogen hormone therapy (E-HT) reduces breast cancer risk, while estrogen plus progestin hormone therapy (EP-HT) increases it, especially with long-term use. The study analyzed data from ...

October marks Breast Cancer Awareness Month, a time dedicated to raising awareness about breast health and the importance of early detection. This year, The Estée Lauder Companies have launched the ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

After 3 years of follow-up in the Mammary Prevention 3 (MAP.3) randomized trial, women who took exemestane were 65% less likely than those who took a placebo to develop breast cancer. 8 With 7 years ...